# TALC

URL: https://app.greenveil.ai/ingredients/ingredient_cas_14807_96_6
Categories: beauty, industrial, pharma
Functions: Abrasive, Absorbent, Anti-adhesive/cohesive, Anti-caking agent, Deodorizer, Filler, Humectant, Mineral, Opacifer, Pigment, Processing aids not otherwise specified, Volumizing Agent
Identifier: 14807-96-6

> TALC is used as abrasive / absorbent. Greenveil chemical-concern score: 70/100 — High concern based on regulatory listings.. Assessed from 43 sources.

## Safety assessment

- Chemical concern score: 70/100 — High concern based on regulatory listings.
- Confidence: 4
- Rationale: Talc: Hydrated magnesium silicate is restricted in cosmetic products under Annex III of the EU Cosmetics Regulation (EC) 1223/2009.

## Regulatory status

- EU: restricted — Annex III of EU Cosmetics Regulation (EC) 1223/2009: substances which cosmetic products must not contain except subject to the restrictions laid down. Product types: (a) Powdery products intended to be used for children under 3 years of age (b) Other products Conditions of use and warnings: (a) Keep powder away from children's nose and mouth
- US: commercial use observed — EPA CPDat observed this chemical in 13323 composition records across product categories including Construction and building materials, Raw materials, Furniture and furnishings. EPA CPDat classifies this chemical for functional uses including Abrasive, Absorbent, Volumizing Agent.
- US: inactive ingredient database — Route: BUCCAL; Dosage form: GUM, CHEWING; Potency: NA
- US: inactive ingredient database — Route: BUCCAL; Dosage form: TABLET; Potency: 15 mg
- US: inactive ingredient database — Route: ORAL; Dosage form: CAPSULE; Maximum daily exposure: 729 mg
- US: inactive ingredient database — Route: ORAL; Dosage form: CAPSULE, COATED; Maximum daily exposure: 87 mg
- US: inactive ingredient database — Route: ORAL; Dosage form: CAPSULE, COATED PELLETS; Potency: 14 mg
- US: inactive ingredient database — Route: ORAL; Dosage form: CAPSULE, COATED, EXTENDED RELEASE; Maximum daily exposure: 20 mg
- US: inactive ingredient database — Route: ORAL; Dosage form: CAPSULE, DELAYED RELEASE; Maximum daily exposure: 420 mg
- US: inactive ingredient database — Route: ORAL; Dosage form: CAPSULE, EXTENDED RELEASE; Maximum daily exposure: 5119 mg
- US: inactive ingredient database — Route: ORAL; Dosage form: DROPS; Potency: NA
- US: inactive ingredient database — Route: ORAL; Dosage form: ELIXIR; Potency: 4.5 mg/5ml
- US: inactive ingredient database — Route: ORAL; Dosage form: GRANULE; Maximum daily exposure: 322 mg
- US: inactive ingredient database — Route: ORAL; Dosage form: GRANULE, DELAYED RELEASE; Maximum daily exposure: 525 mg
- US: inactive ingredient database — Route: ORAL; Dosage form: GRANULE, FOR SUSPENSION; Maximum daily exposure: 296 mg
- US: inactive ingredient database — Route: ORAL; Dosage form: LOZENGE; Maximum daily exposure: 50 mg
- US: inactive ingredient database — Route: ORAL; Dosage form: PELLET; Maximum daily exposure: 69 mg
- US: inactive ingredient database — Route: ORAL; Dosage form: POWDER, FOR SUSPENSION; Maximum daily exposure: 735 mg
- US: inactive ingredient database — Route: ORAL; Dosage form: SUSPENSION; Maximum daily exposure: 234 mg
- US: inactive ingredient database — Route: ORAL; Dosage form: SUSPENSION, EXTENDED RELEASE; Maximum daily exposure: 46 mg
- US: inactive ingredient database — Route: ORAL; Dosage form: TABLET; Potency: 1000 mg
- US: inactive ingredient database — Route: ORAL; Dosage form: TABLET, CHEWABLE; Maximum daily exposure: 202 mg
- US: inactive ingredient database — Route: ORAL; Dosage form: TABLET, CHEWABLE, EXTENDED RELEASE; Maximum daily exposure: 18 mg
- US: inactive ingredient database — Route: ORAL; Dosage form: TABLET, COATED; Potency: 320.75 mg
- US: inactive ingredient database — Route: ORAL; Dosage form: TABLET, DELAYED RELEASE; Maximum daily exposure: 349 mg
- US: inactive ingredient database — Route: ORAL; Dosage form: TABLET, DELAYED RELEASE PARTICLES; Maximum daily exposure: 56 mg
- US: inactive ingredient database — Route: ORAL; Dosage form: TABLET, EXTENDED RELEASE; Maximum daily exposure: 300 mg
- US: inactive ingredient database — Route: ORAL; Dosage form: TABLET, FILM COATED; Maximum daily exposure: 91 mg
- US: inactive ingredient database — Route: ORAL; Dosage form: TABLET, FILM COATED, EXTENDED RELEASE; Maximum daily exposure: 60 mg
- US: inactive ingredient database — Route: ORAL; Dosage form: TABLET, FOR SUSPENSION; Maximum daily exposure: 24 mg
- US: inactive ingredient database — Route: ORAL; Dosage form: TABLET, ORALLY DISINTEGRATING; Maximum daily exposure: 80 mg
- US: inactive ingredient database — Route: ORAL; Dosage form: TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE; Maximum daily exposure: 357 mg
- US: inactive ingredient database — Route: ORAL; Dosage form: TABLET, SUGAR COATED; Potency: NA
- US: inactive ingredient database — Route: RECTAL; Dosage form: TABLET; Potency: 32.4 mg
- US: inactive ingredient database — Route: SUBLINGUAL; Dosage form: TABLET; Potency: 32.4 mg
- US: inactive ingredient database — Route: TOPICAL; Dosage form: OINTMENT; Potency: 74.6 %w/w
- US: inactive ingredient database — Route: TOPICAL; Dosage form: POWDER; Maximum daily exposure: 9235 mg
- US: marketed drug occurrence — FDA NDC lists this ingredient in 4 active drug products and 4 total products.
- US: listed in openFDA substance — openFDA substance registry classifies this ingredient as concept.
- US: listed in openFDA substance — openFDA substance registry classifies this ingredient as chemical.

_Assessed by Greenveil._